Lessons on Scaling Innovation in Entrenched Industries

The transition from practitioner to entrepreneur often reveals that the most significant barriers to progress are systemic rather than technical. Drawing from his experience as an OB-GYN and the founder of NeoGenomics, the author argues that true industry disruption requires more than just scientific advancement; it demands a deep understanding of market timing, distribution, and the courage to endure the long gap between innovation and widespread adoption. In complex sectors like healthcare, success is rarely about the elegance of the product, but rather its ability to integrate into existing workflows and gain the trust of the end user.

One of the most critical insights for founders is the necessity of prioritizing distribution and adoption over pure product development. In highly regulated or relationship-driven industries, technical superiority is often secondary to accessibility. The author notes that many startups fail because they focus on building for the gatekeepers—administrators or payers—rather than the individuals the system is intended to serve. By centering the user experience and simplifying complex processes, founders can create a competitive advantage that is far more durable than any single feature set.

Ultimately, the author emphasizes that establishing credibility is a strategic imperative that compounds over time. Building trust acts as a powerful moat that competitors cannot easily replicate. For those looking to reshape entrenched industries, the lesson is clear: identify the gap between what is scientifically possible and what the market currently believes, and prepare for a long-term commitment to changing behaviors at scale. As AI and other emerging technologies continue to evolve, the founders who define the next two decades will be those who act early to build systems that prioritize human-centric outcomes over institutional convenience.